- New energy-efficient EPYC Embedded 9004 Series combines embedded system-optimized features, enhanced security and scalability up to 96 cores —
- Siemens and Advantech are initial customers deploying solutions based on EPYC Embedded 9004 Series —
Immutep Reports Improved And Statistically Significant Survival Benefit For Three Key Patient Groups In Final Phase IIb AIPAC Study Results In Metastatic Breast Cancer
Final Overall Survival (OS) data supports Phase III clinical development of efti in combination with paclitaxel in metastatic breast cancer
OS benefit trend in total population, with median survival benefit of +2.9
